Innate Pharma (IPHA) Cash & Equivalents (2017 - 2026)
Innate Pharma's Cash & Equivalents was $7.51 million in the quarter ended Jun 30, 2026, down 90.0% from $75.16 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Cash & Equivalents (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at Innate Pharma came in at $31.74 million, down 55.8% from the prior year.
- Cash & Equivalents has now declined for six consecutive years, with a five-year compound annual growth rate of -27.3% (years ended Dec 2020 to Dec 2025).
- In earlier years, Cash & Equivalents was $71.86 million in the year ended Dec 31, 2024 (-5.9%), $76.37 million in the year ended Dec 31, 2023 (-14.0%), $88.77 million in the year ended Dec 31, 2022 (-25.2%) and $118.69 million in the year ended Dec 31, 2021 (-24.0%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Cash & Equivalents in data going back to the quarter ended Dec 31, 2017.
- The year-over-year decline in Cash & Equivalents has ranged between 1.2% (the quarter ended Jun 30, 2025) and 90.0% (the quarter ended Jun 30, 2026) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Innate Pharma | 152.76 Mn | 152.76 Mn | - | 7.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.51 Mn |
| Dec 31, 2025 | 32.70 Mn |
| Jun 30, 2025 | 75.16 Mn |
| Dec 31, 2024 | 70.95 Mn |
| Jun 30, 2024 | 76.03 Mn |
| Dec 31, 2023 | 75.97 Mn |
| Jun 30, 2023 | 91.71 Mn |
| Dec 31, 2022 | 85.93 Mn |
| Jun 30, 2022 | 109.85 Mn |
| Dec 31, 2021 | 118.69 Mn |
| Jun 30, 2021 | 125.22 Mn |
| Dec 31, 2020 | 163.10 Mn |
| Jun 30, 2020 | 131.54 Mn |
| Dec 31, 2019 | 224.57 Mn |
| Jun 30, 2019 | 171.15 Mn |
| Dec 31, 2018 | 173.85 Mn |
| Dec 31, 2017 | 117.00 Mn |
API Access
Innate Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();